He succeeds Andrew Oakley, who will focus on opportunities outside Actelion. Muller will take office on 1 September.
He succeeds Andrew Oakley, who will focus on opportunities outside Actelion. Muller will take office on 1 September.
Jill will head the department which oversees all aspects of order handling and delivery and will be responsible for...
Catherine is a seasoned finance executive with 20 years of international experience at senior levels in major...
Jesper joined the company in 1987, and has worked in markets around the world –most recently as senior vice president...
In this newly created role, Dr Menrad will be responsible for developing and executing the Company’s research...
In this newly created role, Dr Menrad will be responsible for developing and executing the Company’s research...
In her new role, Amanda will work across all the key healthcare sectors that Doctors.net.uk operates in, including...
Ms Devgan’s scientific training includes a doctorate in Molecular, Cellular, and Developmental Biology from Yale...
Kelly has over 10 years’ worth of experience in NHS informatics coupled with a passion to help shape the future of NHS...
Kevin will lead brand development, marketing and pricing strategy as a core part of the commercialisation process for...
Dr Kolli brings extensive NHS and pharmaceutical industry experience to LEO Pharma, gained from a career in both the...
Ian is currently non-executive chairman of Multiplicom NV, focused on the development and commercialization of DNA...
Paul joins Internis from Sandoz, where he was Head of Biopharmaceuticals. Paul began his career with Galen 16 years...
Kunz brings exceptional worldwide leadership experience to DIA as former president of the Global Health and Life...
Carsten Hellmann joins Sanofi from Chr. Hansen Holding A/S and will take the position of Executive Vice President...